DOI : 10.1055/s-00000059

Pneumologie

Issue S 01 · Volume 73 · March 2019 DOI: 10.1055/s-009-42542


60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.
München, 13.–16.03.2019

Kongresspräsident: Prof. Dr. med. Jürgen Behr, München

P641
Ghofrani, HA; Sitbon, O; Chin, K; Channick, R; Di Scala, L; Gaine, S; Lang, I; McLaughlin, V; Preiss, R; Rubin, L; Simonneau, G; Tapson, V; Galie, N; Hoeper, MM: Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study
P475
Egenlauf, B; Marra, AM; Harutyunova, S; Halank, M; Benjamin, N; Bossone, E; Cittadini, A; Eichstaedt, C; Fischer, C; Gall, H; Ghofrani, HA; Hoeper, MM; Lange, TJ; Olsson, KM; Grünig, E: Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
P289
Walthelm, J; Joa, F; Langen, HJ; Bohn, J; Bley, T; Guhlmann, CA; Seybold, S; Buck, A; Held, M: Bedeutung der MRT in der Differenzierung pulmonaler Perfusionsausfälle – intestinale Vaskulitis und non-vaskulitische CTEPH – ein Fallbericht
P171
Barnikel, M; Kneidinger, N; Klenner, F; Waelde, A; Arnold, P; Sonneck, T; Behr, J; Neurohr, C; Milger, K: Real-life Erfahrungen mit Selexipag in der Therapie der Pulmonalen Hypertonie
P682
Pan, Z; Benjamin, N; Eichstaedt, C; Blank, N; Lorenz, HM; Fiehn, C; Song, J; Xanthouli, P; Harutyunova, S; Egenlauf, B; Marra, AM; Fischer, C; Grünig, E: Early treatment of Borderline Pulmonary Arterial Hypertension associated with Systemic Sclerosis: a randomized, controlled, double-blind, parallel group, proof-of-concept study